Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Clinical Nutrition Market
Clinical Nutrition Market Analysis
- Report ID: GMI1324
- Published Date: Jan 2023
- Report Format: PDF
Clinical Nutrition Market Analysis
Based on product, the clinical nutrition market size from enteral nutrition segment was valued at more than USD 17.1 billion in 2022. Increasing cases of pediatric gastrointestinal disorders across the globe are likely to outline the market scenario. Enteral nutrition is usually prescribed to patients with partially functioning gut to effectively fulfil their energy as well as nutrient requirements. Often people with gastrointestinal disorders are not able to meet their day-to-day nutrition requirements through regular food intake, making enteral feeding integral for their health. This type of clinical nutrition is efficacious in most cases of GI disorders due to its ability to deliver enhanced patient outcomes without many complications.
Based on consumer, clinical nutrition market from the pediatric consumer segment is slated to surpass USD 78.2 billion by 2032, driven by the surging prevalence of poverty and overpopulation in underdeveloped nations. Poverty and overpopulation is an unfortunate mix that often leads to malnourishment among children. As per the World Bank, more than 10 million people, approximately 41.8% of the population fell under the extreme poverty line in Niger, an underdeveloped West African country, in 2021.
Based on distribution channel, the retail stores segment held over 42% revenue share of the clinical nutrition market in 2022, driven primarily by the better availability of clinical nutrition products in retail stores. With growing brand awareness among potential consumers, the ease of access facilitated by retail outlets is allowing manufacturers to capitalize on the emerging market scenario. Many retail stores also conduct frequent nutritional awareness programs, and educational, and health screening initiatives to raise awareness in the community and address their health needs, further shaping the segment outlook.
Europe clinical nutrition market valuation is anticipated to surpass USD 30.5 billion by 2032, on account of the growing prevalence of cancer cases in the region. An increasing number of cancer patients in Europe suffering from nutritional deficiency. Apart from cancer, increasing occurrence of gastrointestinal, infectious, mechanical, and metabolic complications in the region is also creating a large consumer base for the market. U.S. Clinical Nutrition industry is expected to register over 9% CAGR from 2023 to 2032, due to the increasing incidence of chronic diseases.
Frequently Asked Questions (FAQ) :
Clinical Nutrition Market Scope
